. Author manuscript; available in PMC: 2013 Aug 19.

Published in final edited form as: Cancer Chemother Pharmacol. 2009 May 7;65(1):67–71. doi: 10.1007/s00280-009-1003-z

Table 2.

Characteristics of study participants at enrollment

Gender	11 male, 10 female
Age	Range, 39–83; mean, 65 years; median, 67 years
Ethnicity	15 (71%) White non-Hispanic
	3 (14%) White Hispanic
	3 (14%) Asian
Stage	19 (91%) Stage IV; 2 (9%) Stage IIIB
Karnofsky performance status (KPS)	Number of patients
60	1
70	4
80	13
90	1
Not recorded	2